CAN016: China's Novel Dual-Payload ADC Gains Clinical Approval to Tackle ADC Resistance
May 22, 2026 17:44
CST Updated
May 23, 02:18
Innovent
High-end Biologics Developer
Kanghong Pharmaceutical
Comprehensive pharmaceutical product manufacturer
Alphamab Oncology
Developer of Antibody and Protein Macromolecule Drugs